An NMR-Based Approach to Identify Urinary Metabolites Associated with Acute Physical Exercise and Cardiorespiratory Fitness in Healthy Humans—Results of the KarMeN Study by Kistner, Sina et al.
metabolites
H
OH
OH
Article
An NMR-Based Approach to Identify Urinary
Metabolites Associated with Acute Physical Exercise
and Cardiorespiratory Fitness in Healthy
Humans—Results of the KarMeN Study
Sina Kistner 1,* , Manuela J. Rist 2 , Maik Döring 2, Claudia Dörr 2, Rainer Neumann 1,†,
Sascha Härtel 1,‡ and Achim Bub 1,2
1 Institute of Sports and Sports Science, Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany;
rainer.neumann@ph-karlsruhe.de (R.N.); sascha.haertel@achtzehn99.de (S.H.); achim.bub@kit.edu (A.B.)
2 Department of Physiology and Biochemistry of Nutrition, Max Rubner-Institut, 76131 Karlsruhe, Germany;
manuela.rist@mri.bund.de (M.J.R.); maik.doering@mri.bund.de (M.D.); claudia.doerr@mri.bund.de (C.D.)
* Correspondence: sina.kistner@kit.edu; Tel.: +49-721-608-46981
† Present address: Institute of Movement and Sport, Karlsruhe University of Education,
76133 Karlsruhe, Germany.
‡ Present address: TSG 1899 Hoffenheim, 74939 Zuzenhausen, Germany.
Received: 16 April 2020; Accepted: 19 May 2020; Published: 21 May 2020


Abstract: Knowledge on metabolites distinguishing the metabolic response to acute physical exercise
between fit and less fit individuals could clarify mechanisms and metabolic pathways contributing
to the beneficial adaptations to exercise. By analyzing data from the cross-sectional KarMeN
(Karlsruhe Metabolomics and Nutrition) study, we characterized the acute effects of a standardized
exercise tolerance test on urinary metabolites of 255 healthy women and men. In a second step,
we aimed to detect a urinary metabolite pattern associated with the cardiorespiratory fitness (CRF),
which was determined by measuring the peak oxygen uptake (VO2peak) during incremental exercise.
Spot urine samples were collected pre- and post-exercise and 47 urinary metabolites were identified by
nuclear magnetic resonance (NMR) spectroscopy. While the univariate analysis of pre-to-post-exercise
differences revealed significant alterations in 37 urinary metabolites, principal component analysis
(PCA) did not show a clear separation of the pre- and post-exercise urine samples. Moreover, both
bivariate correlation and multiple linear regression analyses revealed only weak relationships between
the VO2peak and single urinary metabolites or urinary metabolic pattern, when adjusting for covariates
like age, sex, menopausal status, and lean body mass (LBM). Taken as a whole, our results show that
several urinary metabolites (e.g., lactate, pyruvate, alanine, and acetate) reflect acute exercise-induced
alterations in the human metabolism. However, as neither pre- and post-exercise levels nor the fold
changes of urinary metabolites substantially accounted for the variation of the covariate-adjusted
VO2peak, our results furthermore indicate that the urinary metabolites identified in this study do
not allow to draw conclusions on the individual’s physical fitness status. Studies investigating the
relationship between the human metabolome and functional variables like the CRF should adjust for
confounders like age, sex, menopausal status, and LBM.
Keywords: metabolomics; urinary metabolome; urinary metabolites; NMR spectroscopy;
acute physical exercise; cardiorespiratory fitness; VO2peak; exercise metabolomics
1. Introduction
Over the past decades, a growing body of evidence has demonstrated the inverse relationship
between the cardiorespiratory fitness (CRF) and all-cause and disease-specific mortality [1,2]. As one
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of the most widely investigated physiological parameters [1], the CRF is assessed by measuring the
maximal oxygen uptake (VO2max) during an incremental exercise test until exhaustion [3]. If the
VO2max cannot be determined with certainty, requiring the presence of a plateau in oxygen uptake
(VO2), the VO2peak as the highest value of VO2 attained during an incremental test is frequently used
instead [4]. Representing an individual’s ability to take up, transport, and utilize oxygen during
sustained physical exercise [5], the CRF is influenced by a variety of factors such as age [6,7], sex [7,8],
lean body mass (LBM) [9], or heredity [10]. Furthermore, behavioral factors like diet, smoking, alcohol
intake, and particularly physical activity are associated with the CRF [7,11]. Regular physical exercise
is known to induce physiological adaptations like an increased cardiac output or skeletal muscle
capillarization as well as an augmented activity of mitochondrial enzymes, resulting in a higher aerobic
capacity [12]. These alterations are accompanied by a change in skeletal muscle fuel selection during
acute exercise, being reflected in an increased ratio of fat to carbohydrate oxidation [13]. However,
the molecular mechanisms and metabolic pathways underlying the whole-body and skeletal muscle
adaptation to physical exercise still remain to be completely elucidated [14].
The emerging field of metabolomics has the potential to simultaneously analyze a wide range
of metabolites [15], thereby facilitating a more comprehensive characterization of exercise-induced
changes in human metabolism. As the human metabolome reflects the end-product of interactions
between genes, proteins, and the cellular environment [15], investigating the impact of acute or chronic
physical activity on a high number and variety of metabolites can provide novel insights into the
underlying biochemistry of exercise, possibly hinting at specific metabolic pathways related to the
phenotypic response of the human organism to exercise [16,17]. Thus, metabolomics might contribute
to the identification of exercise-responsive biomarkers, which are reflective of the individual fitness
status. Particularly with regard to the health benefits associated with a high CRF, the investigation
of metabolic differences between more and less fit individuals is of great interest not only for sport
scientists but also for physicians in the context of exercise prescription and health examination [18].
Until now, several studies have examined both the acute [19–29] and chronic [30–35] effects of
exercise on the human metabolome by using metabolomics. Although blood represents the most widely
used biofluid in metabolomics research [15], recent publications have demonstrated the ability of urine
as a non-invasive biological material to reflect acute exercise-induced perturbations in metabolism,
e.g., after short-term exercise at maximal intensities [21,22,27] or submaximal endurance exercise [26,29].
However, to the best of our knowledge, no previous study has investigated to what extent the urinary
metabolome responds to a standard exercise tolerance test, during which individuals perform a
stepwise progressive exercise program until exhaustion.
A few metabolomics studies have provided first evidence of changes in the blood metabolome
due to maximal incremental exercise testing on either bicycle ergometer [19,23,24] or treadmill [19].
Interestingly, Lewis et al. demonstrated that the exercise-induced excursions of some plasma metabolites
differentiated between more and less fit individuals, pointing out the possibility that these metabolites
could represent important mediators of the salutary effects of exercise and potential biomarkers of
physical fitness [19]. With regard to the relationship between acute exercise-related changes in urinary
metabolites and the physical fitness status, research is rather scarce. Three studies investigating the
alterations in the urinary metabolome due to submaximal endurance exercise [25,26] or short-term
intensive exercise [21] either compared the exercise-induced changes in urinary metabolites between
groups of different training status [21,26] or aimed to predict the VO2max with the post-exercise urinary
metabolite pattern [25]. However, limitations of existing studies are the relatively small sample sizes,
ranging from 10 [25] to 22 [21] participants, and the moderate number of quantified analytes (11 [21]
or 27 [26] metabolites, respectively) in two of the mentioned studies. Besides, results are partly
restricted to young women [21] or middle-aged men [26] and therefore hardly transferable to the
general population.
Based on the limited data available on exercise-induced excursions of urinary metabolites being
associated with physical fitness and due to the fact that no previous study has investigated to what
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extent the body’s response to a standardized incremental exercise is reflected in the urinary metabolome,
we pursued two major objectives with our study. Firstly, we aimed to characterize acute alterations in
urinary metabolites due to a standardized exercise tolerance test on a bicycle ergometer until individual
exhaustion, which was performed by 255 healthy women and men of the cross-sectional KarMeN
(Karlsruhe Metabolomics and Nutrition) study. The second aim was to investigate if either the urinary
metabolites at rest, post-exercise, or the ratio of the post- to pre-exercise metabolite concentrations are
associated with the CRF, which was determined by measuring the VO2peak. As the metabolomics data
were obtained from a comparatively large and heterogeneous population, this study was particularly
suitable to analyze in how far urinary metabolite pattern can account for the variation in the VO2peak,
when simultaneously considering covariates like age, sex, menopausal status, and LBM—all factors
determining both the physical fitness [7,36] and the human metabolome [37–41]. A targeted nuclear
magnetic resonance (NMR)-based approach was applied to quantify the pre- and post-exercise urinary
levels of 47 metabolites. Ranging from organic acids, keto acids, alcohols to purine derivatives and
amino acids, the detected metabolites represent a relatively broad spectrum of organic compounds
found in the human urinary metabolome [42]. Urine as a biological specimen was chosen because it is
easily accessible, stable, and under less homeostatic regulation than other biofluids [42,43].
2. Results
2.1. Basic Characteristics of Study Participants
Basic characteristics of the KarMeN study participants who were included in the present data
analysis are summarized by means and standard deviations in Table 1. Our study sample consisted
of 255 healthy individuals, 148 men (58%) and 107 women (42%) with a mean age of 46.1 years.
During the incremental exercise test, participants reached a mean absolute VO2peak of 2.83 L min−1.
As the VO2peak was strongly associated with sex and menopausal status (coefficient of determination,
R2 = 0.59), age (R2 = 0.35), and LBM (R2 = 0.69), subsequent correlation and regression analyses were
adjusted for these factors (see Sections 2.3.1 and 2.3.2).
Table 1. Basic characteristics of KarMeN (Karlsruhe Metabolomics and Nutrition) study participants
(total and stratified by sex).
Characteristics of Participants Total (n = 255) Men (n = 148) Women (n = 107) 1
Age (years) 46.1 ± 16.9 * 42.8 ± 17.6 50.7 ± 14.7
Body weight (kg) 72.5 ± 11.6 * 78.5 ± 10.0 64.2 ± 8.1
Height (cm) 174.6 ± 9.6 * 180.1 ± 7.5 166.9 ± 6.5
BMI (kg (m2)−1) 23.7 ± 2.8 * 24.2 ± 2.7 23.1 ± 2.9
LBM (kg) 50.6 ± 10.4 * 58.0 ± 6.6 40.3 ± 3.8
Fat mass (%) 27.9 ± 8.7 * 23.2 ± 6.5 34.5 ± 6.7
Hemoglobin (g dL−1) 2 14.4 ± 1.1 * 15.0 ± 0.9 13.5 ± 0.8
BP systolic (mmHg) 123.6 ± 15.4 * 127.2 ± 13.6 118.6 ± 16.4
BP diasystolic (mmHg) 83.1 ± 10.5 83.9 ± 10.2 82.1 ± 10.9
HRrest (bpm) 62.4 ± 9.4 * 59.9 ± 9.3 65.8 ± 8.6
VO2peak, absolute (L min−1) 2.83 ± 1.00 * 3.46 ± 0.81 1.96 ± 0.42
VO2peak, relative (mL kg−1 min−1) 38.8 ± 11.6 * 44.5 ± 10.7 30.9 ± 7.4
PIAT (watt) 144.5 ± 46.2 * 170.5 ± 41.1 108.4 ± 22.6
Pmax (watt) 215.2 ± 69.1 * 257.0 ± 56.0 157.5 ± 36.0
HRmax (bpm) 170.8 ± 16.8 * 174.1 ± 16.1 166.2 ± 16.8
All values in mean ± SD; 1 n = 49 in the pre- and n = 58 in the post-menopausal state on the examination day;
2 n = 254 (total), n = 106 (women); * p < 0.05, significant difference between women and men by Welch’s t-test;
BP: blood pressure; BMI: body mass index; HRmax: maximum heart rate; HRres: resting heart rate; LBM: lean body
mass; PIAT: power at individual anaerobic threshold; Pmax: maximal power; VO2peak: peak oxygen uptake.
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2.2. Alterations of Urinary Metabolites in Response to a Standardized Exercise Test
2.2.1. Uni- and Bivariate Analysis
By using an NMR-based approach, a total of 47 urinary metabolites were identified and quantified
in spot urine samples collected before and after a standardized incremental exercise test and measured
concentrations were normalized to the osmolality of urine samples. To describe and compare the
metabolite excursions, fold changes (FCs) between the normalized post- and pre-exercise urinary
metabolite concentrations were calculated per participant. In Table 2, alterations in the urinary
metabolite levels are summarized, with metabolites being ranked according to their median fold change
(FC). The normalized absolute urinary metabolite concentrations before and after the bicycle ergometer
test are additionally presented in the Supplementary Table S1 and as boxplots in the Supplementary
Figure S1. Boxplots of the FCs of urinary metabolites are provided in the Supplementary Figure S2.
Table 2. Changes in urinary metabolites after a standardized incremental exercise test.
Nr. Metabolite (Abbreviation) Median Fold Change(25th, 75th Percentiles)
FDR-Corrected
p-Value
1 Lactate (Lac) 4.70 (1.64, 32.98) <0.0001
2 Mannitol (Man) 2.34 (1.30, 4.29) <0.0001
3 trans-Aconitate (t-Aco) 1.96 (1.05, 3.49) <0.0001
4 Alanine (Ala) 1.74 (1.38, 2.20) <0.0001
5 Carnitine (Car) 1.68 (1.24, 2.37) <0.0001
6 Acetate (Acet) 1.55 (1.14, 2.68) <0.0001
7 Taurine (Tau) 1.49 (1.19, 2.02) <0.0001
8 Pyruvate (Pyr) 1.48 (0.88, 3.57) <0.0001
9 Threonine (Thr) 1.40 (1.12, 1.86) <0.0001
10 Guanidoacetate (Gua) 1.39 (1.14, 1.71) <0.0001
11 N,N-Dimethylglycine (DMG) 1.38 (1.13, 1.68) <0.0001
12 Betaine (Bet) 1.32 (1.12, 1.58) <0.0001
13 Glycine (Gly) 1.32 (1.13, 1.63) <0.0001
14 Histidine (His) 1.30 (1.07, 1.62) <0.0001
15 Succinate (Suc) 1.30 (0.92, 1.76) <0.0001
16 cis-Aconitate (c-Aco) 1.29 (1.08, 1.74) <0.0001
17 Methylsuccinate (MSuc) 1.28 (1.12, 1.54) <0.0001
18 Leucine (Leu) 1.28 (1.05, 1.71) <0.0001
19 Acetone (Ace) 1.28 (0.85, 1.99) <0.0001
20 Creatine (Cre) 1.26 (0.85, 1.91) <0.0001
21 Citrate (Cit) 1.24 (1.05, 1.48) <0.0001
22 2-Hydroxyisobutyrate (2-OH-Isob) 1.24 (1.07, 1.43) <0.0001
23 Isoleucine (Ile) 1.21 (0.94, 1.49) <0.0001
24 4-Hydroxyphenylacetate (4-OH-Phe) 1.19 (0.97, 1.69) <0.0001
25 Formate (For) 1.16 (0.96, 1.36) <0.0001
26 3-Aminoisobutyrate (BAIBA) 1.15 (0.94, 1.40) <0.0001
27 Valine (Val) 1.14 (0.97, 1.39) <0.0001
28 3-Hydroxyisovalerate (3-OH-Isov) 1.13 (1.02, 1.28) <0.0001
29 Gluconate (Glu) 1.13 (0.92, 1.44) <0.0001
30 Tyrosine (Tyr) 1.12 (0.97, 1.41) <0.0001
31 Tartrate (Tar) 1.12 (0.74, 1.51) 0.8643
32 Methylamine (MA) 1.10 (0.93, 1.41) <0.0001
33 Dimethylsulfone (DMS) 1.09 (0.87, 1.43) 0.0013
34 Glycolate (Glyc) 1.07 (0.86, 1.27) 0.0066
35 Methanol (Met) 1.07 (0.71, 1.72) 0.1777
36 Urea (Urea) 1.03 (0.87, 1.20) 0.0715
37 Pseudouridine (Pse) 1.03 (0.88, 1.20) 0.1605
38 Dimethylamine (DMA) 1.02 (0.86, 1.21) 0.2783
39 Hypoxanthine (Hyp) 1.00 (0.67, 1.65) 0.4068
40 Uracil (Ura) 0.98 (0.79, 1.22) 0.2208
Metabolites 2020, 10, 212 5 of 26
Table 2. Cont.
Nr. Metabolite (Abbreviation) Median Fold Change(25th, 75th Percentiles)
FDR-Corrected
p-Value
41 Creatinine (Crea) 0.98 (0.84, 1.18) 0.7036
42 1-Methylnicotinamide (MNA) 0.97 (0.78, 1.24) 0.3221
43 Trimethylamine N-oxide (TMAO) 0.97 (0.79, 1.19) 0.0778
44 3-Methylxanthine (3-MXan) 0.90 (0.70, 1.16) <0.0001
45 3-Indoxylsulfate (3-Ind) 0.87 (0.68, 1.04) <0.0001
46 Trigonelline (Tri) 0.73 (0.63, 0.89) <0.0001
47 Hippurate (Hip) 0.70 (0.54, 0.91) <0.0001
For each metabolite, fold changes (FCs) between normalized post- and pre-exercise concentrations were calculated
per participant and presented as median, 25th and 75th percentiles. Significant pre-to-post-exercise differences are
shown by false discovery rate (FDR)-corrected p-values obtained by Wilcoxon’s signed-rank test. Metabolites are
sorted from high to low median FCs. Exercise-responsive metabolites (i.e., metabolites with FDR-adjusted p-values
< 0.05 and median FCs ≤ or ≥ 1.1, respectively) are indicated in italics.
Univariate analysis revealed that 37 out of the 47 measured metabolites showed a significantly
different urinary excretion post-exercise when compared to pre-exercise. While six of these metabolites
(lactate, mannitol, trans-aconitate, alanine, carnitine, and acetate) demonstrated a median FC ≥ 1.5,
17 metabolites showed a median FC between 1.2 and 1.5, 10 metabolites exhibited a median FC between
1.0 and 1.2, two metabolites demonstrated a median FC between 0.8 and 1.0, and two metabolites
showed a median FC ≤ 0.8. To facilitate the detection of exercise-responsive metabolites, which were
defined as metabolites with FDR-adjusted p-values < 0.05 and median FCs ≤ 11.1 or ≥ 1.1, respectively,
the significance and magnitude of the post-to-pre-exercise differences are visualized in a volcano plot
(see Appendix A Figure A1). Due to the relatively high inter-individual variation observed in the
metabolite FC data and due to the known effect of sex on human metabolite profiles, we additionally
investigated if there were any sex-related differences in urinary metabolite FCs. However, with
the exception of citrate and trans-aconitate, women and men did not show any further significant
difference in metabolite FCs. In the Supplementary Table S2, results of the sex-stratified analysis of
pre-to-post-exercise changes are presented.
Especially in the exercise-induced excursions of the urinary lactate excretion, a high variance
between individuals was detected (see Table 2 and Supplementary Figure S2). When analyzing the
associations between the FCs of lactate as the main exercise-responsive metabolite and the FCs of all
other metabolites, it was shown that the exercise-related change in the urinary lactate excretion was
most closely linked to alterations in the urinary excretion of pyruvate (r = 0.76), alanine (r = 0.62),
methylsuccinate (r = 0.57), acetate (r = 0.56), and hypoxanthine (r = 0.56), see Supplementary Table S3.
2.2.2. Multivariate Analysis
Principal component analysis (PCA) was applied as an unsupervised method to describe the
differentiation in the metabolite profile between pre- and post-exercise urine samples. Two different
approaches were conducted to compare either the participants in the pre- and post-exercise condition
(based on a data matrix of 2 × 255 participants and 47 metabolites) or the pre- and post-exercise urinary
metabolite profile (based on a data matrix of 2 × 47 metabolites and 255 participants). With regard to
the first approach, no clear separation of the participants to either the pre- or post-exercise state was
visible in the score plots of the first three principal components (PCs) (see Figure 1 and Supplementary
Figure S3a). However, with respect to the second approach, a partial separation between the pre-
and post-exercise metabolite profile could be observed in the loading plots of the first three PCs.
The metabolite with the greatest change in correlation to the first principle component (PC) between
the pre- and post-exercise condition is Lactate (Lac). The separation of the other metabolites was
mainly detectable in the second and third PC (see Figure 2 and Supplementary Figure S3b).
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or post-exercise state; right: loading plot, data points stand for metabolites.
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the participants; right: loading plot, data points stand for metabolites and are color coded according to
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2.3. Relationship between the Cardiorespiratory Fitness Status and Urinary Metabolites
Different exploratory approaches were applied to investigate the relationship between urinary
metabolite measures and the CRF status. Firstly, we focused on bivariate associations between
the VO2peak and single metabolite measures, followed by partial associations independent of
phenotypic variables known to determine both the VO2peak and the metabolome (see Section 2.3.1).
Secondly, multiple linear regression analyses were conducted to examine the relationship between the
VO2peak and all urinary metabolites simultaneously (see Section 2.3.2). To assess which of the metabolite
measures (pre-exercise, post-exercise, or the post-to-pre-exercise ratio, i.e., FC) correlates best with the
VO2peak, all analyses were performed separately for each of the three metabolite parameters.
2.3.1. Bivariate Analyses
Pearson correlation coefficients and partial correlations adjusted for age, sex, menopausal status,
and LBM were calculated for the associations of the VO2peak with urinary metabolite measures and
presented in the Supplementary Table S4. Correlations were considered statistically significant when
the 95% confidence intervals did not include zero. A visual comparison of the pairwise associations is
additionally provided in correlation heat maps (see Figure 3 for post-exercise measures and Appendix A
Figure A2 or Figure A3 for the pre-exercise measures and FCs, respectively).
Results of the unadjusted correlations revealed that 22 pre-exercise urinary metabolites,
24 post-exercise urinary metabolites, and seven FCs of urinary metabolites showed a correlation with the
VO2peak which was significantly different from zero. With regard to the pre-exercise metabolite measures,
the strongest correlations were observed for citrate (r =−0.46), guanidoacetate (r =−0.39), lactate (r = −0.38),
trigonelline (r = −0.35), and succinate (r = −0.32), see Appendix A Figure A2 (right/up; 1st row). For the
post-exercise metabolite measures, guanidoacetate (r = −0.41), citrate (r = −0.39), gluconate (r = −0.36),
trigonelline (r = −0.36), creatine (r = −0.35), hippurate (r = −0.34), and succinate (r = −0.31) were most
strongly associated with the VO2peak, see Figure 3 (right/up; 1st row). When regarding the FCs of urinary
metabolites, correlations with the VO2peak were comparatively low with r ≤ 0.3 or ≥ −0.3, respectively,
see Appendix A Figure A3 (right/up; 1st row).
To examine if the described correlations were dependent on certain influencing factors such as age,
sex, menopausal status, and LBM, both the VO2peak and the urinary metabolite measures were adjusted
for these factors and correlation analyses were performed on the corresponding residuals. Results of the
partial correlation analyses showed that only three pre-exercise urinary metabolites, three post-exercise
urinary metabolites and two FCs of urinary metabolites exhibited a partial correlation with the VO2peak
which was significantly different from zero. After adjusting for confounding factors, the most correlated
urinary metabolite measures included pre-exercise histidine (r = −0.17), tyrosine (r = −0.16), and uracil
(r = 0.16), post-exercise tyrosine (r = −0.18), 1-methylnicotinamide (r = −0.15), and guanidoacetate
(r = −0.12) as well as the FCs of urinary 1-methylnicotinamide (r = −0.13) and hypoxanthine (r = −0.13),
see Supplementary Table S4 and Figures 3, A2 and A3, respectively (left/down; 1st column). In addition,
bivariate correlations of age and LBM with the VO2peak and the urinary metabolite measures confirmed
that these factors were strongly correlated with the VO2peak and weakly to moderately associated with
some urinary metabolite parameters (see 2nd and 3rd row in Figures 3, A2 and A3, respectively).
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2.3.2. Multivariate Analyses
To analyze the relationship between the VO2peak and all urinary metabolites at once, several multiple
linear regr ssion procedures were conduct d. By adjusting both the VO2peak as the d pendent variabl and
the u nary metabolite measures as the independent variables for age, sex, menopausal status, and LBM,
the investigated association wer uncorrelated with these phenotypic variables.
When all 47 urinary metabolite eas r i l ed into a multiple linear regression model,
the adjusted pre-exercise urinary metabolites explained t e ariati i t e adjusted VO2peak to 29.5%
(R2 = 0.295, R2 (adjusted) = 0.135). hile the adjusted post-exercise urinary metabolites similarly
accounted for up to 29.6% (R2 = 0.296, R2 (adjusted) = 0.137) of the variation in the adjusted VO2peak,
the inclusion of all 47 adjusted FCs of urinary metabolites resulted in a comparatively lower proportion
of explained variance in the adjusted VO2peak (R2 = 0.141, R2 (adjusted) = −0.054).
In a next step, we aimed to select the best set of urinary metabolite variables describing the adjusted
VO2peak. Therefore, two stepwise regression models with either forward or backward selection were
performed for each metabolite measure (i.e., pre-exercise, post-exercise and FC). The results of the stepwise
regression analyses are presented in the Supplementary Table S5, together with a ranking of the adjusted
metabolite variables according to their contribution for explaining the adjusted VO2peak. As a criterion for
the selection of urinary metabolite variables, the Bayesian information criterion (BIC) was used. For each
metabolite measure, the model with the lowest BIC was chosen and the respective metabolite variables
were entered into a final multiple linear model. The included urinary metabolite variables as well as
criteria for the evaluation and comparison of the three final models are summarized in Table 3.
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With regard to the pre-exercise metabolite measures, seven urinary metabolite variables were
included into the final model, resulting in an adjusted R2 of 0.153 and a BIC of 300.9. For the
post-exercise metabolite measures, three urinary metabolite variables were selected for the final model,
which showed a comparatively lower adjusted R2 of 0.070 and a higher BIC of 306.6. When regarding
the FCs of urinary metabolites, the model with the minimal BIC did not contain any metabolite
variables. Thus, the intercept-only model was obtained for the explanation of the adjusted VO2peak
based on the urinary metabolite FCs.
Table 3. Final multiple linear models for the adjusted VO2peak.
Model R2 R
2
(Adjusted)
BIC Std.-Beta 95% CI(Lower)
95% CI
(Upper)
Pre 0.176 0.153 300.9
cis-Aconitate −0.441 −0.291 −0.106
3-Aminoisobutyrate 0.232 0.047 0.163
trans-Aconitate 0.295 0.054 0.212
Tyrosine −0.213 −0.157 −0.038
Guanidoacetate −0.208 −0.165 −0.038
Uracil 0.206 0.033 0.156
Lactate 0.230 0.041 0.218
Post 0.081 0.070 306.6
Tyrosine −0.197 −0.145 −0.034
3-Aminoisobutyrate 0.182 0.028 0.141
1-Methylnicotinamide −0.149 −0.126 −0.013
Fold changes 0.000 0.000 311.4
(intercept-only model)
Metabolite variables were selected based on the results of the stepwise regression analyses. All variables
were Van der Waerden-transformed prior to analysis and adjusted for age, sex, menopausal status, and LBM.
BIC: Bayesian information criterion, CI: confidence interval (of the corresponding regression coefficient in the
considered linear model), R2: coefficient of determination, R2 (Adjusted): adjusted coefficient of determination,
Std.-Beta: Standard-Beta (corresponding regression coefficient using only standardized variables).
Apart from the multiple regression analyses, PCA was performed using either the adjusted pre-
or post-exercise urinary metabolite data or the adjusted data on urinary metabolite FCs, in order to
detect clusters of participants potentially related to their physical fitness status. The first three principal
components were visualized in score and loading plots (see Supplementary Figure S3c–e). In the
score plots, the data points were color coded according to the individual VO2peak of the participants.
No evident cluster of participants with a similar fitness level could be detected based on the pre- or
post-exercise urinary metabolite profile, respectively. Nor did we observe a grouping of participants
with a similar fitness level when conducting the PCA on urinary metabolite FCs.
3. Discussion
The main finding of this study is that 37 out of 47 measured metabolites showed a significantly
different urinary concentration post-exercise when compared to pre-exercise. While the strongest
increase was observed for urinary lactate, mannitol, trans-aconitate, alanine, carnitine, and acetate
(all demonstrating a median FC > 1.5), the strongest decrease was observed for urinary hippurate
and trigonelline (both demonstrating a median FC < 0.8). However, PCA did not permit a clear
separation of the pre- and post-exercise urine samples. With regard to the investigated relationship
between the VO2peak and urinary metabolites, both bivariate correlation and multiple linear regression
analyses revealed only weak associations when adjusting for confounding covariates like age, sex,
menopausal status, and LBM. In the following sub-sections, the post-exercise alterations in urinary
metabolites (see Section 3.1) as well as their relation to the CRF status of the KarMeN study participants
(see Section 3.2) are discussed.
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3.1. Post-Exercise Alterations in Urinary Metabolites Are Partly Reflective of Energy Metabolism
The pre-to-post-exercise comparison of urinary metabolite concentrations confirmed some
well-established exercise-induced changes in pathways related to energy metabolism. However, some
novel urinary metabolites being altered in response to acute exercise were also revealed. A summary
of the origin and pathways of the identified metabolites and the documented effect of acute exercise on
urinary metabolite levels is provided in Appendix A Figure A4.
The highest post-exercise increase was observed for urinary lactate (median FC = 4.70), which can
be explained by an enhanced carbohydrate catabolism in the exercising muscles. During an incremental
exercise test, individuals continuously utilize an increased amount of adenosine triphosphate (ATP).
To maintain the muscular ATP resynthesis rate, the required energy is initially provided by mainly
aerobic processes and then, with augmented intensity, to an increased degree by the anaerobic
energy system [44]. As the end-product of anaerobic glucose breakdown, lactate is released into
the blood stream and partly excreted via urine [45]. The documented increase in urinary lactate
elimination is in accordance with the results of other exercise metabolomics studies [21,22,25–27,29],
even though the magnitude of urinary lactate excretion was generally greater in response to maximal
exercise protocols [22,27,29]. When compared with other metabolites, we observed a remarkably high
inter-individual variation in the post-exercise urinary lactate concentrations. Unfortunately, we were
unable to explain this variation by any of the measured physiological parameters and assume it to be
a result of the heterogeneous study population and further influencing factors (e.g., the maximally
reached exercise intensity, the anaerobic lactic capacity, or the elimination rate of lactate from muscle
via blood to urine). However, despite the high variation in the lactate FCs, we noticed that those
persons with a high increase in urinary lactate also showed a high increase in urinary pyruvate, alanine
and acetate—all metabolites resulting from interconnected metabolic pathways (see Supplementary
Table S2 and Appendix A Figure A4). For instance, the post-exercise increase of urinary pyruvate
(median FC = 1.48) can equally be seen as a result of an increased glycolysis. When the pyruvate
production rate during exercise is higher than the capacity of the mitochondria to take up pyruvate, the
skeletal muscle has to remove it from the cytosol [46]. Thus, pyruvate is either directly released into
the blood or previously converted to lactate via lactate dehydrogenase reaction [46] or to alanine via
transamination [45], thereby providing substrates for gluconeogenesis in the liver [45,47]. Our results
demonstrated a median 1.74-fold increase in the urinary alanine excretion due to exercise, which is in
line with previous work [21,26,27,29]. As the alanine flux into the bloodstream during exercise was
shown to be higher than the alanine uptake by the liver [48], it can be assumed that this amino acid
accumulated in blood and was therefore excreted via urine after the incremental test. Next to pyruvate
and alanine, the post-exercise increase in urinary lactate was accompanied by a median 1.55-fold
increase in urinary acetate, confirming the results of previous studies investigating the effect of acute
exercise on the urinary metabolome [21,26,27]. Two mechanisms for explaining this observation are
discussed in the literature. Firstly, the rise in urinary acetate is likely to be the consequence of an
increased hydrolysis of acetyl-CoA, which was produced from pyruvate but could not entirely enter into
the tricarboxylic acid (TCA) cycle and was therefore released into the blood [27,49]. Secondly, acetate
might be directly produced in a radical-removing reaction from pyruvate, which seems able to convert
reactive oxygen species into carbon dioxide and acetate [50,51].
With regard to the remaining amino acids (Gly, His, Ile, Leu, Tau, Thr, Tyr, Val), we observed a
post-exercise increase in their urinary excretion, reaching from a median 1.12-fold (Tyr) to a median
1.49-fold (Tau) rise. This observation points to higher circulating amino acid concentrations, but it
remains speculative if this was due to an increased exercise-induced protein degradation or to a
higher amino acids availability owing to the breakfast participants consumed after the first spot
urine collection. Although the rise in urinary alanine was consistent across several exercise-related
metabolomics studies, this global increase in amino acids has not been detected in previous work.
While Siopi et al. could confirm a higher urinary excretion of glycine, histidine, taurine, tyrosine,
and threonine 2 h after high-intensity interval and continuous moderate exercise [29], other studies
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documented an unchanged urinary excretion of taurine [22,27], isoleucine, leucine, and valine [22] or a
decreased level in urinary glycine [22,26,27], leucine [25], histidine [22], threonine [25], and tyrosine [27],
respectively, in response to the different exercise protocols. With respect to the increase in urinary
taurine, a semi-essential amino acid highly concentrated in human muscles [52], it can be supposed that
the acute exercise resulted in an increased muscular taurine release. Consistent with this explanation,
previous work has demonstrated an exercise-induced release of taurine from contracting muscles due
to osmoregulatory processes, leading to a higher taurine level in both blood and urine [53]. However,
as the urinary excretion of taurine furthermore depends on the dietary taurine intake [54], it cannot
be completely excluded that the intake of taurine-containing food like cheese at breakfast led to the
observed increase in urinary taurine excretion.
Four further metabolites related to amino acid metabolism showed a post-exercise increase in their
urinary level, namely methylsuccinate (median FC = 1.28) and 3-hydroxyisovalerate (median FC = 1.13),
both byproducts of the leucine degradation pathway [55,56], 4-hydroxyphenylacetate (median
FC = 1.19), a degradation product of tyrosine, and 3-aminoisobutyrate (median FC = 1.15),
a valine degradation product and recently discovered myokine [57]. The amino acid derivative
N,N-dimethylglycine (median FC = 1.38) and guanidoacetate (median FC = 1.39), an intermediate in
the metabolic pathway of several amino acids, were also reported to be elevated in the post-exercise
urine samples. To our knowledge, no earlier metabolomics studies have reported exercise-related
changes in the urinary concentration of these metabolites.
With regard to metabolites of the TCA cycle (i.e., citrate, cis-aconitate and succinate), a median
1.24- to 1.30-fold increase in their urinary levels was observed post-exercise. A significant rise in urinary
succinate has previously been documented in response to a 30 s maximal sprint [21], whereas a decrease
in both urinary succinate [26,27] and citrate [22,26,27,29] was reported after intermittent [22,27,29] or
submaximal exercise [26,29]. Compared to this, other studies showed that acute exercise was followed
by an increase in plasma TCA cycle intermediates, suggesting that these compounds spilled over
from muscle into the circulation due to an increased TCA cycle flux [58,59]. However, whether the
increased post-exercise urinary excretion of TCA cycle metabolites in our study also can be traced back
to this explanation, remains unclear. Interestingly, we observed that women had a lower fold change
of urinary citrate than men (median 1.16- vs. 1.29-FC). This might hint at sex-specific differences in
exercise-related citrate turnover.
To our knowledge, this is the first study reporting a post-exercise increase in the urinary excretion
of carnitine (median FC = 1.68). Carnitine, which can either be synthesized from the amino acid
lysine or ingested through diet, is largely stored in the skeletal muscle, where it is involved in the
translocation of long-chain fatty acids into the mitochondrial matrix for subsequent β-oxidation and
the buffering of accumulating acetyl-CoA [60]. Previous work has shown that acute exercise results
in a higher muscle and plasma concentration of acetylcarnitines (reflecting an enhanced pyruvate
and fatty acids oxidation) or long-chain acylcarnitines (reflecting an increased mobilization of free
fatty acids) [24,61–64], accompanied by a decrease in muscular [62,65] and blood [61,62] free carnitine.
However, neither a decreased nor an increased urinary excretion of free carnitine has been noticed so
far [22,27,65].
In addition to carnitine, urinary mannitol and trans-aconitate demonstrated a more than 1.9-fold
increase in response to the incremental exercise test. Mannitol is a polyol found in many foods and
used as an artificial sweetener. It is produced by microorganisms [66] and cannot be metabolized
by humans [67]. Although an exercise-related increase of urinary mannitol was also shown by
Siopi et al. [29], the reasons for this alteration are currently unclear. As mannitol in urine seems to show
diurnal variation [68], an effect of time on the mannitol excretion cannot be excluded. Trans-aconitate
is an organic acid present in plants like wheat or soybean and seems not to be degraded in human
metabolism [69]. Since participants of this study consumed wheat bread before exercising, it is
presumable that the increase in urinary trans-aconitate was due to its dietary intake and not owing
to acute physical exercise. That women demonstrated a higher increase in urinary trans-aconitate
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than men (median 2.33- vs. 1.53-FC) could indicate sex-related differences in the biokinetics of
absorbed trans-aconitate.
With regard to betaine (median FC = 1.32), an increased urinary excretion has previously been
documented in response to intermittent and submaximal endurance exercise [29]. Betaine functions
as an organic osmolyte and methyl donor; it is endogenously produced or ingested through foods
like wheat or spinach [70]. However, as the urinary betaine excretion seems to be relatively stable,
not being considerably affected by food intake or hydration status [71], we are currently unable to
explain the observed increase in urinary betaine. Similarly, it is unclear why the level of urinary
acetone (median FC = 1.28) increased after exercise. The ketone body is produced in the liver
when there is a shortage of carbohydrates, e.g., during prolonged exercise or in the fasting state [72].
Concerning creatine, there is one study confirming the post-exercise increase in its urinary excretion [29]
and one study showing opposite results [25]. Altogether, the observed increases in urinary creatine,
formate, gluconate, and methylamine can hardly be explained and might be due to uncontrolled
variation. However, one interesting finding is the post-exercise rise in the urinary excretion of
2-hydroxyisobutyrate (median FC = 1.24), which was already shown in previous exercise metabolomics
studies [27,29]. Urinary 2-hydroxyisobutyrate is mainly known as a degradation product of gasoline
additives entering the body through inhalational exposure [73]. Recently, it was also suggested to be
a gut microbial metabolite [74] and an indicator of the increased lactate production due to alcohol
consumption [75]. As the same carrier protein seems to be responsible for the (re)absorption of both
lactate and 2-hydroxyisobutyrate in the kidney, it was assumed that elevated lactate levels inhibit the
2-hydroxyisobutyrate reabsorption rate, thus contributing to an increase in its urinary excretion [75].
However, it remains largely speculative if this mechanism also underlay the exercise-related increase
of urinary 2-hydroxyisobutyrate in this study.
The four metabolites showing a decrease in the post-exercise urine samples were identified as
either microbial cometabolites (3-indoxylsulfate [76] and hippurate [77]) or diet-related metabolites
(3-methylxanthine [78] and trigonelline [79]; both markers of coffee consumption). As we could not
find a relevant link between these metabolites and acute exercise, we assume that the observed decline
in their urinary levels was due to uncontrolled variation.
Rather unexpectedly, no change was documented in the urinary excretion of hypoxanthine,
the final ATP degradation product, which is known to be released during exercise from muscles
to blood and excreted via urine [80]. In agreement with its proposed function as an indicator of
exercise-related energetic stress [80,81], hypoxanthine was increased in the post-exercise urine samples
of several metabolomics studies [21,22,25–27,29]. The discrepant results could be explained by a
comparatively lower exercise intensity or duration in the KarMeN study or a time point of sample
taking that was too early to capture the post-exercise rise of hypoxanthine in urine.
With regard to our multivariate approaches, we could not observe a clear distinction between
the pre- and post-exercise urine samples (see Figure 1), suggesting that the incremental exercise test
did not cause a substantial variation in the overall urinary metabolite profile. Conversely, the PCA
loading plots in Figures 2 and S3b showed a partial separation between the pre- and post-exercise
urinary metabolites which was predominantly detectable in the second and third PC. These results
indicate that there was a variation in the urinary metabolite profile which, however, could not
primarily and solely be attributed to the performed exercise. Although the results of our univariate
analysis revealed that 37 out of 47 urinary metabolites significantly changed in response to exercise,
it was also apparent that the degree of changes in urinary metabolites was less profound than in
other exercise-related metabolomics studies [21,22,27,29]. Furthermore, we generally observed a
high inter-individual variability in urinary metabolite concentrations and calculated FCs, which was
probably due to the heterogeneous study population and the fact that the dietary intake on the day
before the bicycle ergometry was not standardized. Taken together, discrepancies regarding the type,
duration, and intensity of exercise as well as the time point of sample taking and the selected study
population only allowed a limited comparison of our results to other studies. What additionally has to
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be taken into account when interpreting our findings is that large sample sizes like in this study can
amplify the detection of statistically significant metabolite changes, which are, however, not necessarily
biologically relevant [82]. However, as we could detect known exercise-related metabolite changes
being reflected in the urinary metabolome, we conclude that metabolomics studies focusing on urine
need to control for physical activity.
3.2. Urinary Metabolites at Rest and after Exercise Are Not Substantially Related to Physical Fitness
Despite a high inter-individual variance in both the analyzed urinary metabolites and the VO2peak,
we revealed only weak to moderate associations between the CRF and the pre- and post-exercise
urinary metabolite profile or the exercise-related metabolite FCs, respectively. When comparing
the results of the single and partial correlation analyses, it became obvious that the associations
between the VO2peak and the urinary metabolite variables were strongly influenced by age, sex,
menopausal status, and LBM. After adjusting for these covariates, only few single urinary metabolites
showed weak correlations with the VO2peak which were significantly different from zero, namely
pre-exercise urinary histidine (r = −0.17), tyrosine (r = −0.16), and uracil (r = 0.16), post-exercise urinary
1-methylnicotinamide (r = −0.15), guanidoacetate (r = −0.12), and tyrosine (r = −0.18) and fold changes
of urinary 1-methylnicotinamide (r = −0.13) and hypoxanthine (r = −0.13). Even if no reliable urinary
marker for the VO2peak could be detected in this study, our results hint at a few potentially interesting
urinary metabolites that are independently of known covariates linked to the VO2peak. For example,
the slight negative association between pre-exercise urinary histidine and the VO2peak is in line with a
previous study documenting a significant lower urinary histidine excretion in a high-fitness group
compared to a low-fitness group [31]. As opposed to this, the weak negative association between the
FC of urinary hypoxanthine and the VO2peak does not confirm previous results from Mukherjee et al.
who showed that more fit individuals demonstrated a higher increase in urinary hypoxanthine after a
submaximal endurance exercise than less fit participants [26]. The discrepant results could be explained
by distinct approaches to detect differences in post-exercise metabolite alterations or by different study
populations. We used correlation and regression analyses instead of group comparisons to be able to
draw conclusions across a broad range of fitness levels in healthy women and men. Previous studies
characterizing the human urinary metabolome in relation to acute exercise and the fitness status mainly
observed fitness-associated differences in exercise-induced metabolite changes between pre-defined
groups of either athletes or untrained persons [21,26]. We suppose that maybe an athletic background
with several years of training and possibly a distinct genetic background is necessary to substantially
alter metabolic pathways.
Our multivariate approaches, which analyzed the relationship between the adjusted VO2peak and
all urinary metabolites at once, showed that there was no evident metabolic pattern related to the
fitness status in neither the pre- nor the post-exercise condition. Thus, it can be summarized that the 47
analyzed metabolites do not strongly account for the variation in the CRF after having adjusted for
age, sex, menopausal status, and LBM. When furthermore comparing the ability of selected urinary
metabolite variables to explain the variation in the adjusted VO2peak, we noticed that the adjusted
pre-exercise urinary metabolites resulted in a comparatively better model in the sense of BIC than the
adjusted post-exercise urinary metabolites or respective FCs. This observation indicates that acute
changes in urinary metabolites might primarily be driven by the energy requirements due to the
performed exercise and less reflective of the individual’s fitness status.
3.3. Strengths and Limitations
The present study has several strengths and limitations. Firstly, a high number of healthy
women and men with a wide age range were included in this study, which was characterized by
highly standardized clinical and physiological examinations and a strictly scheduled experimental
setting. Thus, we were able to investigate how urinary metabolites are associated with both acute
physical exercise and the CRF status in a comparatively large population. Additionally, owing to
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the comprehensive characterization of study participants, potential confounders like age, sex, LBM,
and menopausal status could be considered. To furthermore minimize the variability in metabolomics
measurements, pre-menopausal women were scheduled for the bicycle ergometry within the luteal
phase of their menstrual cycle. One limitation of this study is that the time point of post-exercise
urine sampling was not strictly controlled. Participants were told to collect their first available spot
urine after having completed the incremental test, which was approximately 15–30 min post-exercise.
Besides, as the participants collected the pre-exercise spot urine samples before breakfast, it has to be
taken into account that the urinary metabolite changes could be related to both the post-exercise and
the post-prandial state. Additionally, no causal relationships between the individual’s fitness status
and the metabolome can be proven due to the cross-sectional study design.
Even though our NMR-based analysis had the advantage to allow the absolute quantification
of urinary metabolites with known identity and of different chemical classes, this targeted approach
was limited to a comparatively small selection of urinary compounds. In future studies, it would be
appropriate to analyze the acute and chronic effects of physical exercise on a broader spectrum of
metabolites in both blood and urine.
4. Materials and Methods
4.1. Subjects and Study Design
The Karlsruhe Metabolomics and Nutrition (KarMeN) study is a cross-sectional study which
was performed between March 2012 and July 2013 at the Division of Human Studies of the Max
Rubner-Institut in Karlsruhe, Germany. The main objective of the KarMeN study was to investigate the
impact of sex, age, body composition, and major lifestyle factors like diet and physical activity on the
metabolome of healthy women and men. Detailed information about inclusion and exclusion criteria
as well as a detailed description of the study design were provided in Bub et al. [83]. Briefly, 301 healthy,
non-smoking individuals (172 men, 129 women) between 18 and 80 years were included. Volunteers
were thoroughly characterized by anthropometric and clinical examinations. The body composition
was assessed by dual-energy X-ray absorptiometry (DXA; Lunar iDXA, GE Healthcare, Germany) and
lean body mass (LBM) and fat mass were calculated with the supplementary software enCOREv16.
Blood hemoglobin was measured by a certified clinical chemistry laboratory (MZV Labor PD Dr.
Volkmann, Karlsruhe, Germany). Furthermore, resting energy expenditure and CRF were assessed and
data on regular physical activity and menopausal status in women were collected. As the menstrual
cycle is known to influence metabolite profiles [84], all premenopausal women were scheduled for
examinations within their luteal phase. The study was approved by the ethics committee of the State
Medical Chamber of Baden-Württemberg, Stuttgart, Germany and was conducted in accordance
with the declaration of Helsinki. The study was registered at the German Clinical Trials Register
(DRKS00004890). The WHO universal trial number is U1111-1141-7051. Written informed consent was
obtained from all participants prior to entering the study.
4.2. Exercise Examination Day and Urine Sample Collection
On the exercise examination day, participants entered the study center early in the morning.
Before the bicycle ergometry started, volunteers passed a resting phase for the indirect calorimetry
measurement (40 min), consumed a standardized breakfast consisting of two slices of wheat bread
with butter and either cheese, ham, or jam (20 min) and had a second resting phase for answering
the International Physical Activity Questionnaire (20 min). Immediately after entering the study
center, all participants provided fasting spot urine into 100 mL polypropylene collection cups (Sarstedt,
Nümbrecht, Germany). This was approximately 90 min before the bicycle ergometry started. In addition
to that, the first available spot urine after the completion of the exercise test was obtained from all
participants approximately 15–30 min post-exercise.
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Participants performed a standardized exercise test on a bicycle ergometer (Ergobike medical,
Daum, Fürth, Germany) until individual maximal performance was reached, see Biniaminov et al. [85].
Briefly, according to the WHO-loading protocol [86], each participant started pedaling at 25 Watt
and workload was then augmented by 25 Watt every 2 min until individual exhaustion. Respiratory
gas exchange was measured breath-by-breath by using a cardiopulmonary exercise testing system
(MetaMax 3B, Cortex, Leipzig, Germany). As a measure of physical fitness, the peak oxygen uptake
(VO2peak) was determined. The VO2peak was defined as the highest achieved oxygen uptake during
the test. It is either expressed as an absolute value in L min−1 or relative to the body weight in mL
kg−1 min−1. Further important endpoints of the incremental test were the maximal power (Pmax),
maximum heart rate (HRmax), and the power at individual anaerobic threshold (PIAT). The PIAT was
determined by the Ergonizer software (Ergonizer, Version 4, Freiburg, Germany) after having measured
lactate in capillary blood samples taken from the individual’s earlobe before, during and after the
test. Throughout the entire procedure, the heart rate was recorded by a heart rate monitor (T31 coded,
Polar Electro GmbH Deutschland, Büttelborn, Germany). Additionally, a continuous hemodynamic
monitoring was conducted by running a 12-channel electrocardiogram (CardioDirect 12, DelMar
Reynolds GmbH, Feucht, Germany) and by measuring the blood pressure every 2–3 min on the right
upper arm (boso Carat professional, Bosch + Sohn, Jungingen, Germany). Break-off criteria for the
maximal exercise test were predefined according to national ergometry standards and listed in the
following: ST-segment depression > 3 mm, ST-segment elevation > 1 mm, acute hypertension with
systolic blood pressure > 230 mmHg or diastolic blood pressure > 115 mmHg, appearance of angina
pectoris symptoms or severe dyspnea.
4.3. Urine Sample Preparation
After urine sample collections, all urine specimens were centrifuged at 1850 g at 4 ◦C for 10 min
and transferred into prechilled cryovials. They were initially frozen at −20 ◦C for one day and
then cryopreserved at −196 ◦C until analysis. As previously shown, this procedure does not affect
metabolomics results [87].
4.4. 1H-NMR Analysis
In order to identify and quantify a relatively broad range of urinary metabolites before and after
the cycle ergometry, all urine samples were analyzed by 1D-1H-NMR spectroscopy. As previously
described [37], urine samples were centrifuged and supernatants were mixed with 10% of a buffer
containing 1.5 M KH2PO4, 2 mM NaN3, and 5.8 mM trimethylsilylpropanoic acid (TSP) in D2O at
pH 7.4 in 5 mm NMR tubes (Duran, purchased from Roth GmbH & Co KG, Karlsruhe, Germany).
Samples were measured at 300 K on a Bruker 600 MHz spectrometer (either AVANCE III equipped
with a 1H,13C,15N-TCI inversely detected cryoprobe or AVANCE II with 1H-BBI room temperature
probe (Bruker BioSpin GmbH, Rheinstetten, Germany)) equipped with either SampleXpress or BACS
sample changer using a 1D nuclear overhauser enhancement spectroscopy (NOESY) experiment with
presaturation for water suppression. A prescan delay of 4 s was used together with a mixing time
of 10 ms. Pulse lengths were determined automatically by the Bruker AU program, pulsecal. 64 k
complex data points corresponding to a sweep width of 20 ppm were recorded. All spectra were
treated identically using an exponential apodization function, introducing an additional linewidth of
0.3 Hz and automated phasing, baseline correction, and referencing using the Bruker macro, apk0.noe.
Quality control (QC) samples were prepared by pooling urine samples from all participants. On each
measurement day, at least three QC samples were analyzed along with approximately 70 urine study
samples, ensuring the comparability of the spectra over the time. Since alignment of metabolites in urine
spectra for non-targeted analysis is still very challenging, a targeted NMR-based metabolomic approach
was applied. The identification and quantification of 47 urinary metabolites, including organic acids,
amino acids, amines, sugars, sugar alcohols, and others was carried out with the Chenomx NMR Suite
8.4 (Chenomx, Edmonton, AB, Canada). Further metabolites could either not be detected in each urine
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sample or not identified and/or quantified with sufficient confidence. Imprecision was generally <15%,
with few exceptions. No systematic variation between the two spectrometers was observed. Metabolite
concentrations were normalized to osmolality, thus controlling for variations in urine dilution [88],
and results are given in µmol/L per mOsm/kg urine. The osmolality of urine samples was determined
by freezing point depression using an Advanced Instrument Micro-Osmometer model 3MO (Norwood,
MA, USA). The normalized metabolite data as well as the technical precision of the NMR analysis are
presented in the Supplementary Table S1.
4.5. Data Handling and Statistical Analysis
We excluded 46 individuals due to missing spirometry data (n = 40), outlying urinary metabolite
concentrations (n = 5) and implausible data on resting heart rate (n = 1). Thus, data from 255 individuals
were included into the following analyses. Descriptive characteristics of the study participants are
presented as mean and standard deviation (SD) for the total study sample and separately for women
and men. In the Supplementary Table S1, the median and percentiles (25th, 75th) of basic characteristics
are additionally provided. Sex differences in basic characteristics were examined by Welch’s t-test.
For each of the 47 metabolites, fold changes (FCs) between the normalized post- and pre-exercise
concentrations were calculated per participant and shown as median and percentiles (25th, 75th).
Compared to absolute differences in metabolite concentrations, FCs are unitless and therefore easier to
interpret, allowing the direct comparison of exercise-induced excursions between different metabolites.
In the Supplementary Table S1, the entire data on absolute metabolite concentrations and FCs of urinary
metabolites are additionally summarized by the arithmetic mean and SD. As the urinary metabolite
concentrations did not follow a normal distribution, the data were subjected to nonparametric univariate
statistical analysis. In order to identify urinary metabolites that were significantly different between pre-
and post-exercise, Wilcoxon’s signed-rank tests were used. The false discovery rate (FDR) was applied
to correct the obtained p-values for multiple hypothesis testing, using the method of Benjamini and
Hochberg with an extension to the corresponding simultaneous tests. Adjusted p-values were compared
to the level of statistical significance, which was set at α = 0.05. Metabolites with FDR-corrected
p-values < 0.05 and median FCs ≤ 11.1 or ≥ 1.1 were considered as exercise-responsive metabolites.
A volcano plot was provided to visualize the magnitude (FCs) and significance (FDR-corrected p-values)
of differences in urinary metabolites. To compare the metabolite FCs between women and men,
the Wilcoxon rank-sum test was used and FDR-corrected p-values were reported (see Supplementary
Table S2).
Due to the non-normal data distribution and the occurrence of outliers in the urinary metabolite
data, all variables were transformed into Van der Waerden scores prior to the following analyses. In detail,
by using this rank based inverse normal transformation, the data were converted into ranks, transformed
to a scale between 0 and 1 and, then, the corresponding standard normal quantiles were calculated.
To investigate the relationships between the FCs of urinary metabolites, Pearson correlation coefficients
(r) with 95% confidence intervals (CIs) were calculated. Furthermore, PCA analysis was conducted on
the transformed metabolite data, which were centered and scaled to unit variance, in order to visualize
the main variability on a reduced dimensionality. Two different approaches were applied. The first
approach was based on a data matrix of 2 × 255 participants from the pre- and post-exercise condition and
47 metabolites. The second approach dealt with a data matrix of 255 participants and 2 × 47 metabolites
from the pre- and post-exercise condition. Relationships between the VO2peak and either pre- and
post-exercise urinary metabolite concentrations or urinary metabolite FCs were analyzed by Pearson
correlation. To remove any confounding association, we also performed partial correlation analyses by
using the residuals from linear regressions, where both the transformed VO2peak and the transformed
metabolite variables were regressed on age, sex, menopausal status, and LBM.
In a next step, multiple linear regression procedures were conducted to analyze the relationship
between the VO2peak and all urinary metabolite variables simultaneously. Three different models
were calculated with the previously obtained residuals of VO2peak as the dependent variable and the
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residuals of (a) pre-exercise urinary metabolites, (b) post-exercise urinary metabolites, and (c) urinary
metabolite FCs, respectively, entering as independent variables. By this construction, the analyzed
relationships were confounder-adjusted and hence uncorrelated with known determinants of both
the VO2peak and the urinary metabolome. In more detail, two stepwise regression models with either
forward or backward elimination were performed for each (a), (b), and (c) to obtain a ranking of the
adjusted metabolite variables according to their contribution for explaining the adjusted VO2peak.
For the selection and elimination processes, the Bayesian information criterion (BIC) was used. Finally,
based on the results of the stepwise regression procedures, the models with the minimum BIC were
chosen in order to select those metabolite variables which should enter into a suitable final model.
The adjusted coefficients of determination (R2 (adjusted)) were used to compare the three obtained final
models with respect to their potential in explaining the variation of the adjusted VO2peak. Statistical
analysis was performed using SAS JMP 11.0.0. (SAS Institute Inc. 2013, Cary, NC, USA) and the
software R Version 3.6.0 [89], using the packages XLConnect [90], ggplot2 [91], ggpubr [92], corrplot [93],
and ggrepel [94]. The R-script for figure generation is provided in the Supplementary File S1.
5. Conclusions
We investigated the effect of a standardized exercise tolerance test on 47 urinary metabolites of 255
healthy women and men. Besides, we analyzed whether the VO2peak measured in the incremental test
is associated with exercise-related metabolite excursions and pre- or post-exercise urinary metabolite
pattern. Although PCA analysis did not show a clear separation of the pre- and post-exercise urine
samples, univariate analysis revealed significant pre-to-post-exercise alterations in the urinary excretion
of 37 metabolites—with the strongest increase being observed for lactate, mannitol, trans-aconitate,
alanine, carnitine, and acetate. However, only weak relationships between the VO2peak and single
urinary metabolites or urinary metabolite pattern, respectively, could be revealed after adjusting for
covariates like age, sex, menopausal status, and LBM. Our findings indicate that the analyzed urinary
metabolites partly reflect acute exercise-related changes in the human metabolism, but do not allow to
conclude about the individual’s fitness status. We recommend future urinary metabolomics studies
to control for acute physical exercise and to consider the mentioned confounders if investigating
functional variables like the VO2peak.
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ATP adenosine triphosphate
BIC Bayesian information criterion
CI confidence interval
CRF cardiorespiratory fitness
DXA dual-energy X-ray absorptiometry
FC fold change
FCs fold changes
FDR false discovery rat
HRmax maximum heart rate
KarMeN Karlsruhe Metabolomics and Nutrition
LBM lean body mass
NMR nuclear magnetic resonance
NOESY nuclear overhauser enhancement spectroscopy
p p-value of context-dependent test
PC principal component
PCA principal component analysis
PCs principal components
PIAT power at individual anaerobic threshold
Pmax maximal power
QC quality control
r Pearson correlation coefficient
R2 coefficient of determination
R2 (adjusted) adjusted coefficient of determination
SD standard deviation
TCA tricarboxylic acid
TSP trimethylsilylpropanoic acid
VO2 oxygen uptake
VO2max maximal oxygen uptake
VO2peak peak oxygen uptake
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Figure A1. Volcano plot of exercise-related changes in urinary metabolites. Y-axis: represents the 
statistical significance of metabolite changes (red line: ΅ = 0.05); X-axis: represents the magnitude of 
metabolite changes (blue lines: FC of 1.1 or ଵଵǤଵ, respectively).Metabolites located in the upper left and 
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Figure A1. Volcano plot of exercise-related changes in urinary metabolites. Y-axis: represents the
statistical significance of metabolite changes (red line: α = 0.05); X-axis: represents the magnitude of
metabolite changes (blue lines: FC of 1.1 or 11.1 , respectively). Metabolites located in the upper left and
upper right part were defined as exercise-responsive etabolites in this study.
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Right/Up: Unadjusted bivariate associations. Left/Low: Partial associations adjusted for age, sex, 
menopausal status, and LBM. Pearson correlations were performed on Van der Waerden-transformed 
data. 
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Right/Up: Unadjusted bivariate associations. Left/Low: Partial associations adjusted for age, sex, 
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data. 
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Figure A4. Pathways and origin of identified metabolites. The post-exercise changes of the urinary metabolites are color coded as follows: red, FC ≥ 1.5 and FDR-
corrected p < 0.05; orange: 1.5 > FC ≥ 1.1 and FDR-corrected p < 0.05; black: 1.1 > FC > ଵଵǤଵ or FDR-corrected p ≥ 0.05; blue: FC ǂ 
ଵ
ଵǤଵ and FDR-corrected p < 0.05; grey: 
undetected metabolites. BCAA: branched-chain amino acids, FC: fold change between normalized post- and pre-exercise urinary metabolite concentrations, FDR: 
false discovery rate, p: p-value obtained by Wilcoxon‘s signed-rank test to analyze significant pre-to-post-exercise differences. 
Figure A4. Pathways and origin of identified metabolites. The post-exercise changes of the urinary metabolites are color coded as follows: red, FC ≥ 1.5 and
FDR-corrected p < 0.05; orange: 1.5 > FC ≥ 1.1 and FDR-corrected p < 0.05; black: 1.1 > FC > 11.1 or FDR-corrected p ≥ 0.05; blue: FC ≤ 11.1 and FDR-corrected p < 0.05;
grey: undetected metabolites. BCAA: branched-chain amino acids, FC: fold change between normalized post- and pre-exercise urinary metabolite concentrations,
FDR: false discovery rate, p: p-value obtained by Wilcoxon‘s signed-rank test to analyze significant pre-to-post-exercise differences.
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